CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults
CDSCO approves SPEVIGO® (spesolimab)
Search
Corporate Social Responsibility
Boehringer Ingelheim is driven by a purpose to positively impact the lives of communities in India. Click here to learn more about our work in this area.
weBuy
weBuy is a key initiative in order to have an integrated solution for the Source to Procure Process around the globe. Click here to find out more.
COVID-19 Making More Health support program
Find out what our communities, local partners and social entrepreneurs in the Making More Health network do. Click here to find out and learn more.
My.Making More Health Website
My.Making More Health, our platform for disadvantaged communities goes live, providing materials on health prevention for all. Click here to learn more.
The Supplier Code of Conduct Download
Click here to download our supplier code of conduct. The Boehringer Ingelheim supplier code of conduct entered into force in 2016, and was updated in 2020.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
Our Employees
We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.
Performance Indicators
All available performance indicators concerning Environment Health and Safety (EHS) are summarised here. Click here to find out more information.